For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
The Europe cardiovascular surgical device market is forecasted to rise at CAGR of 7.60% between the years 2017-2025, collecting around $24196 million by the end of this period.
The European cardiovascular surgical devices market is segmented based on the end-users and the products. The end-users for this market are hospitals, physician's offices, and ASCs. The product segment of the market is further classified into atherectomy devices, cardiac catheters, CRDM, surgeries, imaging, interventional guide wires, cardiovascular stents, LAA closure devices, etc. The high incidence of cardiac disorders and the continuous rise in older population are the key drivers for the expansion of this market. However, the stringent regulation for approval of the devices, the pricing pressure and a lack of product differentiation might prove challenging for the market in the coming years.
GE Healthcare, Abbott Inc, Johnson and Johnson, Atricure Inc, Berlin Heart GMBH, St. Jude Medical, Inc, Philips Healthcare and Cook Medical Inc, are few of the prominent players in this market.